Positive experience of iron hydroxid saccharose complex intravenous infusions in III degree anemic puerperas treatment

  • T.P. Yaremchuk Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
  • R.Ya. Matsiura Lviv Regional Clinical Perinatal Center, Lviv, Ukraine
  • S.R. Matsiura Municipal Non-Commercial Enterprise “5th City Clinical Hospital”, Lviv, Ukraine

Abstract

Objective. To improve the quality of severe anemic puerperas treatment on the ground of evaluation of the clinical efficacy of iron hydroxid saccharose complex intravenous infusions in the treatment of women with III degree hypochromic and posthemorrhagic anemias.

Materials and methods. The materials of research were 392 birth case reports of puerperas with III degree anemia, which gave birth in the Lviv Regional Perinatal Center in the first half of 2020. The methods of research were clinical, laboratory, ultrasound, instrumental, medical-statistical methods. Iron hydroxid saccharose complex infusions in a dose of 200 mg daily were performed in women once or twice with an interval of 2-3 days to receiving of Hb indicator >80 g/l, improving hematological indicators of anemia, disappearance of tachycardia, reducing other anemic syndrome manifestations. Women continued treatment with oral iron supplements under the female polyclinic supervision.

Results and discussion. Totally, 2,493 births and 806 cesarean sections were in Lviv Regional Clinical Perinatal Center, 9 cases of uterine bleedings were registered (0,27+0,09 % of all births) in the first half of 2020. In 0,15+0,07 % of cases obstetric bleedings developed due to uterine atony (0,2+0,09 % of parturitions). Intraoperative atonic obstetric bleedings developed in 0,12+0,06 % (0,5+0,25 % of cesarean sections). Anemias in the postpartum period were diagnosed in 392 puerperas, which formed 11,88+0,56 % of all births. Posthemorrhagic anemias accounted for 2,3+0,76 % of anemias, hypochromic anemias – 97,7+0,76 %. Iron hydroxid saccharose complex infusion was prescribed through one day after delivery. Adverse reactions were absent. Iron hydroxid saccharose complex application allowed to obtain clinical improvement in all cases within 5 days, increase Hb >80 g/l and improve anemia hematological indicators, speed up convalescence.

Conclusions. Iron hydroxid saccharose complex in the treatment of puerperas with III degree anemias (posthemorrhagic and hypochromic) have high clinical efficiency, well tolerated, reduce the hospital treatment duration.

Keywords: puerperas, hypochromic anemia, posthemorrhagic anemia, iron hydroxid saccharose complex.
Published
2020-10-21
How to Cite
Yaremchuk, T., Matsiura, R., & Matsiura, S. (2020). Positive experience of iron hydroxid saccharose complex intravenous infusions in III degree anemic puerperas treatment. Infusion & Chemotherapy, (3.1), 89-89. https://doi.org/10.32902/2663-0338-2020-3.1-74
Section
Materials of IV International Congress of infusion therapy